Radiation-related Lymphopenia after Pelvic Nodal Irradiation for Prostate Cancer

Radiation-related Lymphopenia after Pelvic Nodal Irradiation for Prostate Cancer

Purpose: Given the uncertainty with regard to the effectiveness of pelvic nodal irradiation (PNI) for prostate cancer, we aimed to determine whether patients with prostate cancer who are treated with PNI are at a higher risk of developing radiation-related lymphopenia (RRL). Methods and materials: T...

Full description

Bibliographic Details
Main Authors:	Michael D. Schad, BS, Sunil W. Dutta, MD, Donald M. Muller, MD, Krishni Wijesooriya, PhD, Timothy N. Showalter, MD, MPH
Format:	Article
Language:	English
Published:	Elsevier 2019-04-01
Series:	Advances in Radiation Oncology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2452109419300065

Similar Items

Para-Aortic Nodal Radiation in the Definitive Management of Node-Positive Cervical Cancer
by: Jason C. Sanders, et al.
Published: (2021-04-01)

High-risk prostate cancer treated with a stereotactic body radiation therapy boost following pelvic nodal irradiation
by: Jonathan W. Lischalk, et al.
Published: (2024-02-01)

Elective Nodal Irradiation for Oligorecurrent Nodal Prostate Cancer: Interobserver Variability in the PEACE V-STORM Randomized Phase 3 Trial
by: Orane Lorton, MS Dipl Ing, et al.
Published: (2023-11-01)

Postoperative elective pelvic nodal irradiation compared to prostate bed irradiation in locally advanced prostate cancer – a retrospective analysis of dose-escalated patients
by: Carola Link, et al.
Published: (2019-06-01)

Comparison of Estimated Late Toxicities between IMPT and IMRT Based on Multivariable NTCP Models for High-Risk Prostate Cancers Treated with Pelvic Nodal Radiation
by: Srinivas Chilukuri, MD, et al.
Published: (2022-06-01)

Stereotactic Body Radiation Therapy for Cholangiocarcinoma: Optimizing Locoregional Control With Elective Nodal Irradiation
by: Margaret M. Kozak, MD, et al.
Published: (2020-01-01)

Severe Radiation-Induced Lymphopenia Attenuates the Benefit of Durvalumab After Concurrent Chemoradiotherapy for NSCLC
by: Wang Jing, MD, et al.
Published: (2022-09-01)

Early Tolerance Outcomes of Stereotactic Hypofractionated Accelerated Radiation Therapy Concomitant with Pelvic Node Irradiation in High-risk Prostate Cancer
by: Attapol Pinitpatcharalert, MD, et al.
Published: (2019-04-01)

11C-Choline PET Guided Salvage Radiation Therapy for Isolated Pelvic and Paraortic Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Rationale and Early Genitourinary or Gastrointestinal Toxicities
by: Krishan R. Jethwa, MD, et al.
Published: (2019-10-01)

Assessing the Spleen as an Organ at Risk in Radiation Therapy and Its Relationship With Radiation-Induced Lymphopenia: A Retrospective Study and Literature Review
by: Michire Alexandru, MD, PhD, et al.
Published: (2021-11-01)

Dosimetric Modeling of Lymphopenia in Patients With Metastatic Cancer Receiving Palliative Radiation and PD-1 Immune Checkpoint Inhibitors
by: Jack M. Qian, MD, et al.
Published: (2022-03-01)

Radiation-related lymphopenia is associated with spleen irradiation dose during radiotherapy in patients with hepatocellular carcinoma
by: Jing Liu, et al.
Published: (2017-05-01)

The Distribution of Pelvic Nodal Metastases in Prostate Cancer Reveals Potential to Advance and Personalize Pelvic Radiotherapy
by: Irina Filimonova, et al.
Published: (2021-01-01)

Dosimetric Effect of Thymus and Thoracic Duct on Radiation-Induced Lymphopenia in Patients With Primary Lung Cancer Who Received Thoracic Radiation
by: Jinliang Zhang, MD, et al.
Published: (2023-11-01)

Radiation-Induced Lymphopenia Risks of Photon Versus Proton Therapy for Esophageal Cancer Patients
by: Saba Ebrahimi, BSc, et al.
Published: (2021-04-01)

Salvage Involved-Field and Extended-Field Radiation Therapy in Positron Emission Tomography–Positive Nodal Recurrent Prostate Cancer: Outcomes and Patterns of Failure
by: Adeline Pêtre, MD, et al.
Published: (2023-01-01)

Lymphopenia, Lymphopenia-Induced Proliferation, and Autoimmunity
by: Ting-Ting Sheu, et al.
Published: (2021-04-01)

Vertebral body and splenic irradiation are associated with lymphopenia in localized pancreatic cancer treated with stereotactic body radiation therapy
by: Abhinav V. Reddy, et al.
Published: (2021-12-01)

Lymphopenia and Radiation Dose to Circulating Lymphocytes With Neoadjuvant Chemoradiation in Esophageal Squamous Cell Carcinoma
by: Tsz Him So, FRCR, et al.
Published: (2020-09-01)

Radiation dose to the nodal regions during prone versus supine breast irradiation
by: Csenki M, et al.
Published: (2014-05-01)

Quality of Life after Post-Prostatectomy Intensity Modulated Radiation Therapy: Pelvic Nodal Irradiation Is Not Associated with Worse Bladder, Bowel, or Sexual Outcomes.
by: James M Melotek, et al.
Published: (2015-01-01)

Radiation-Induced Lymphopenia Beyond the COVID-19 Pandemic
by: Giuseppe Carlo Iorio, et al.
Published: (2020-11-01)

Field size effects on the risk and severity of treatment-induced lymphopenia in patients undergoing radiation therapy for solid tumors
by: Susannah G. Ellsworth, MD
Published: (2018-10-01)

Impact of Lymphopenia Recovery After Chemoradiotherapy on Durvalumab Consolidation Therapy in Stage III NSCLC
by: Tomoki Kuge, MD, et al.
Published: (2023-05-01)

Sentinel lymph node imaging guided IMRT for prostate cancer: Individualized pelvic radiation therapy versus RTOG guidelines
by: Chien P. Chen, MD, PhD, et al.
Published: (2016-01-01)

Lymphopenia in diverticulitis.
by: Baker, SR, et al.
Published: (1991)

Treatment of primary rectal adenocarcinoma after prior pelvic radiation: The role of hyperfractionated accelerated reirradiation
by: Garrett Jensen, MD, et al.
Published: (2018-10-01)

CT-Guided Pelvic Lymph Nodal Brachytherapy
by: Hiroaki Kunogi, et al.
Published: (2021-02-01)

Shortened Radiation Time Promotes Recovery From Radiation-induced Lymphopenia in Early-Stage Non-small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy
by: Qianqian Zhao PhD, et al.
Published: (2022-07-01)

The impact of lymphopenia on delirium in ICU patients.
by: Shigeaki Inoue, et al.
Published: (2015-01-01)

Can pelvic node dissection at radical prostatectomy influence the nodal recurrence at salvage lymphadenectomy for prostate cancer?
by: Arjun Sivaraman, et al.
Published: (2018-03-01)

Splenic irradiation contributes to grade ≥ 3 lymphopenia after adjuvant chemoradiation for stomach cancer
by: Shing Fung Lee, et al.
Published: (2022-09-01)

Meta-analysis and Critical Review: Association Between Radio-induced Lymphopenia and Overall Survival in Solid Cancers
by: Yasmine El Houat, MD, et al.
Published: (2023-03-01)

Radiation-induced esophagitis in patients with breast cancer receiving supraclavicular nodal irradiation: A retrospective observational study
by: Zalfa Abdul Azeez, et al.
Published: (2023-01-01)

LYMPHOPENIA: THE MAIN CAUSES
by: N. T. Vatutin, et al.
Published: (2016-05-01)

Feasibility of Dose Escalating [18F]fluciclovine Positron Emission Tomography Positive Pelvic Lymph Nodes During Moderately Hypofractionated Radiation Therapy for High-Risk Prostate Cancer
by: Andrew M. McDonald, MD, et al.
Published: (2019-10-01)

Disparities in staging prostate magnetic resonance imaging utilization for nonmetastatic prostate cancer patients undergoing definitive radiation therapy
by: Ayobami Ajayi, BA, et al.
Published: (2016-10-01)

Radiation Induced Lymphopenia Is Associated With the Effective Dose to the Circulating Immune Cells in Breast Cancer
by: Fang Chen, et al.
Published: (2022-04-01)

Pelvic Insufficiency Fractures and Bone Pain after Radiation Therapy for Anal Cancer: Relation to Pelvic Bone Dose-Volume Parameters
by: Camilla Jensenius Kronborg, MD, PhD, et al.
Published: (2023-01-01)

Platelet-to-albumin ratio and radiation-induced lymphopenia—prognostic biomarker for carcinoma esophagus
by: Adrija Ghosh, et al.
Published: (2024-02-01)